Eduard S. Bel'SKikh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eduard S. Bel'SKikh has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Valentina I. Zvyagina
Ryazan State Medical University Ministry of Health of Russia; 9 Visokovoltnaya St., Ryazan, 390026, Russian Federation
9 shared publications - Oleg Mikhaylovich Uryas'Ev
Ryazan State Medical University named after academician I.P. Pavlov
6 shared publications - Mikhail Mikhailovich Atroshchenko
All-Russian Research Institute for Horse Breeding
3 shared publications - Svetlana V. Faletrova
Ryazan State Medical University named after I.P. Pavlov
3 shared publications - Yuliya A. Marsyanova
Ryazan State Medical University Ministry of Health of Russia; 9 Visokovoltnaya St., Ryazan, 390026, Russian Federation
3 shared publications - Anna M. Shitikova
Ryazan State Medical University
2 shared publications
Latest Publications
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (3) , 25-35
Clinical significance of inspiratory capacity and baseline oxygen saturation in the diagnosis of the desaturation phenotype in patients with chronic obstructive pulmonary disease: a cross-sectional diagnostic accuracy study
BACKGROUND: Exercise-induced desaturation in patients with chronic obstructive pulmonary disease (COPD) without marked resting hypoxemia is associated with an unfavorable disease course. However, the value of readily available clinical and functional parameters for identifying this phenotype remains insufficiently studied. AIM: To identify clinical and functional parameters associated with exercise-induced desaturation in patients with COPD, assess their relationship with patients’ functional status, and determine their diagnostic value for identifying the desaturator phenotype. METHODS: This prospective single-center cross-sectional comparative study included 85 men with stable COPD and moderate or severe airflow limitation. Based on the results of the six-minute walk test, 35 patients were classified as desaturators and 50 as non-desaturators. Spirometry, pulse oximetry, and the six-minute walk test with recording of ventilatory parameters were performed. Statistical analysis included nonparametric tests for between-group comparisons, Spearman correlation analysis, binary logistic regression, ROC analysis, and internal five-fold cross-validation. RESULTS: Patients who developed exercise-induced desaturation had more severe dyspnea according to the mMRC (modified Medical Research Council) scale (p = 0.040) and lower values of forced expiratory volume in 1 second (p = 0.004), maximal voluntary ventilation (p = 0.002), end-exercise and minimum breathing reserve (p = 0.003 and p = 0.011, respectively), and baseline and end-exercise inspiratory capacity (p 0.001 and p = 0.003, respectively). Baseline inspiratory capacity correlated with the work performed during the six-minute walk test (ρ = 0.551, p 0.001). The model incorporating baseline SpO₂ and inspiratory capacity yielded an AUC of 0.903 in the complete sample and 0.894 during internal five-fold cross-validation. CONCLUSION: The exercise-induced desaturation phenotype in patients with COPD is primarily associated with impaired respiratory mechanics and gas exchange. Baseline oxygen saturation and inspiratory capacity are clinically relevant parameters for distinguishing between patients with and without exercise-induced desaturation.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (3) , 25-35
Clinical significance of inspiratory capacity and baseline oxygen saturation in the diagnosis of the desaturation phenotype in patients with chronic obstructive pulmonary disease: a cross-sectional diagnostic accuracy study
BACKGROUND: Exercise-induced desaturation in patients with chronic obstructive pulmonary disease (COPD) without marked resting hypoxemia is associated with an unfavorable disease course. However, the value of readily available clinical and functional parameters for identifying this phenotype remains insufficiently studied. AIM: To identify clinical and functional parameters associated with exercise-induced desaturation in patients with COPD, assess their relationship with patients’ functional status, and determine their diagnostic value for identifying the desaturator phenotype. METHODS: This prospective single-center cross-sectional comparative study included 85 men with stable COPD and moderate or severe airflow limitation. Based on the results of the six-minute walk test, 35 patients were classified as desaturators and 50 as non-desaturators. Spirometry, pulse oximetry, and the six-minute walk test with recording of ventilatory parameters were performed. Statistical analysis included nonparametric tests for between-group comparisons, Spearman correlation analysis, binary logistic regression, ROC analysis, and internal five-fold cross-validation. RESULTS: Patients who developed exercise-induced desaturation had more severe dyspnea according to the mMRC (modified Medical Research Council) scale (p = 0.040) and lower values of forced expiratory volume in 1 second (p = 0.004), maximal voluntary ventilation (p = 0.002), end-exercise and minimum breathing reserve (p = 0.003 and p = 0.011, respectively), and baseline and end-exercise inspiratory capacity (p 0.001 and p = 0.003, respectively). Baseline inspiratory capacity correlated with the work performed during the six-minute walk test (ρ = 0.551, p 0.001). The model incorporating baseline SpO₂ and inspiratory capacity yielded an AUC of 0.903 in the complete sample and 0.894 during internal five-fold cross-validation. CONCLUSION: The exercise-induced desaturation phenotype in patients with COPD is primarily associated with impaired respiratory mechanics and gas exchange. Baseline oxygen saturation and inspiratory capacity are clinically relevant parameters for distinguishing between patients with and without exercise-induced desaturation.
- 7 July 2026
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
METHOD FOR MODELING MILD AND MODERATE FORMS OF HYPERHOMOCYSTEINEMIA IN MALE RATS BY ORAL ADMINISTRATION OF D,L-HOMOCYSTEINE TOIOLACTONE
Introduction. Hyperhomocysteinemia is an independent risk factor for the development of cardiovascular and neurological diseases, as well as re-productive system pathology, which underscores the need for an in-depth study of its pathogenesis. The diversity of etiological factors of hyperhomo-cysteinemia, including genetic predispositions, B vitamin deficiencies, and comorbid conditions, complicates the prediction and management of this state, necessitating the development of adequate experimental models. Existing approaches to modeling hyperhomocysteinemia have a number of methodological limitations, which highlights the importance of creating a reproducible, minimally invasive, and clinically relevant model for investigat-ing the mechanisms of damage and discovering effective methods for therapeutic correction. Objective – to develop a reproducible model of hyperhomocysteinemia (Hcy) in rats. Material and Methods. The study was conducted on adult male Wistar rats (410–430 g) in four groups: control group (n=8), group 2 (n=8) receiving D,L-homocysteine thiolactone (D,L-HT) solution at a dose of 1 g/kg for 7 days, group 3 (n=8) receiving the same dose for 14 days, and group 4 (n=8) receiving D,L-HT at a dose of 3 g/kg for 7 days. D,L-HT solution was administered twice daily with a 7-hour interval. Results. The method of modeling Hcy through intragastric administration of D,L-HT at a dose of 1 g/kg for 7 and 14 days increased homocysteine levels by 4.9 and 7.9 times, respectively (p < 0.05), achieving mild and moderate Hcy. Administration at 3 g/kg elevated Hcy levels by 5.6 times but was associated with high mortality. Conclusion. The method of administering D,L-HT at a dose of 1 g/kg twice daily for 7 and 14 days is effective in modeling mild and moderate Hcy forms, suitable for studying the biological effects of elevated Hcy levels and testing pharmacological interventions
- 7 July 2026
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
METHOD FOR MODELING MILD AND MODERATE FORMS OF HYPERHOMOCYSTEINEMIA IN MALE RATS BY ORAL ADMINISTRATION OF D,L-HOMOCYSTEINE TOIOLACTONE
Introduction. Hyperhomocysteinemia is an independent risk factor for the development of cardiovascular and neurological diseases, as well as re-productive system pathology, which underscores the need for an in-depth study of its pathogenesis. The diversity of etiological factors of hyperhomo-cysteinemia, including genetic predispositions, B vitamin deficiencies, and comorbid conditions, complicates the prediction and management of this state, necessitating the development of adequate experimental models. Existing approaches to modeling hyperhomocysteinemia have a number of methodological limitations, which highlights the importance of creating a reproducible, minimally invasive, and clinically relevant model for investigat-ing the mechanisms of damage and discovering effective methods for therapeutic correction. Objective – to develop a reproducible model of hyperhomocysteinemia (Hcy) in rats. Material and Methods. The study was conducted on adult male Wistar rats (410–430 g) in four groups: control group (n=8), group 2 (n=8) receiving D,L-homocysteine thiolactone (D,L-HT) solution at a dose of 1 g/kg for 7 days, group 3 (n=8) receiving the same dose for 14 days, and group 4 (n=8) receiving D,L-HT at a dose of 3 g/kg for 7 days. D,L-HT solution was administered twice daily with a 7-hour interval. Results. The method of modeling Hcy through intragastric administration of D,L-HT at a dose of 1 g/kg for 7 and 14 days increased homocysteine levels by 4.9 and 7.9 times, respectively (p < 0.05), achieving mild and moderate Hcy. Administration at 3 g/kg elevated Hcy levels by 5.6 times but was associated with high mortality. Conclusion. The method of administering D,L-HT at a dose of 1 g/kg twice daily for 7 and 14 days is effective in modeling mild and moderate Hcy forms, suitable for studying the biological effects of elevated Hcy levels and testing pharmacological interventions
- 24 December 2025
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 15 (4) , 223-231
The Signaling Role of Several Mitochondrial Metabolites in the Regulation of Mitochondrial Homeostasis
This review systematizes contemporary data on the signaling role of mitochondrial metabolites in regulating mitochondrial homeostasis, with an emphasis on their influence on cellular adaptation to stress factors, including age-related changes. Mitochondria function not only as energy sources but also as key sensors and regulators, mediating anterograde and retrograde signaling through metabolites such as citrate, succinate, lactate, and L-carnitine. Citrate and succinate participate in epigenetic modifications, including protein acetylation and succinylation, thereby influencing gene expression and metabolic adaptation, with potential applications in the therapy of oncological and age-associated diseases. Lactate, traditionally regarded as a product of anaerobic metabolism, acts as a signaling molecule that modulates receptor cascades (GPR81), histone lactylation, and oxidative phosphorylation in mitochondria. L-carnitine ensures metabolic flexibility by maintaining the acyl-CoA/CoA balance, removing toxic metabolites, and enhancing nitric oxide bioavailability, demonstrating its protective effects in models of hyperhomocysteinemia and NO deficiency. Understanding these mechanisms opens up prospects for the identification of biomarkers of mitochondrial dysfunction and the development of therapeutic strategies aimed at restoring homeostasis in the context of aging, metabolic disorders, and gerontological syndromes.
- 24 December 2025
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 15 (4) , 223-231
The Signaling Role of Several Mitochondrial Metabolites in the Regulation of Mitochondrial Homeostasis
This review systematizes contemporary data on the signaling role of mitochondrial metabolites in regulating mitochondrial homeostasis, with an emphasis on their influence on cellular adaptation to stress factors, including age-related changes. Mitochondria function not only as energy sources but also as key sensors and regulators, mediating anterograde and retrograde signaling through metabolites such as citrate, succinate, lactate, and L-carnitine. Citrate and succinate participate in epigenetic modifications, including protein acetylation and succinylation, thereby influencing gene expression and metabolic adaptation, with potential applications in the therapy of oncological and age-associated diseases. Lactate, traditionally regarded as a product of anaerobic metabolism, acts as a signaling molecule that modulates receptor cascades (GPR81), histone lactylation, and oxidative phosphorylation in mitochondria. L-carnitine ensures metabolic flexibility by maintaining the acyl-CoA/CoA balance, removing toxic metabolites, and enhancing nitric oxide bioavailability, demonstrating its protective effects in models of hyperhomocysteinemia and NO deficiency. Understanding these mechanisms opens up prospects for the identification of biomarkers of mitochondrial dysfunction and the development of therapeutic strategies aimed at restoring homeostasis in the context of aging, metabolic disorders, and gerontological syndromes.
- Open Access
- 13 January 2025
- Published by Agricultural Research Communication Center in Indian Journal of Animal Research
- No. Of
Role of Caspase 3, Caspase 8 and Caspase 9 in Male Infertility and Sperm Cryoinjury: A Review
Apoptosis is an integral part of sperm development, quality control and differentiation. Caspases are proteolytic enzymes that play a key role in apoptosis. The aim of this review article is to analyze the role of caspases 3, 8 and 9 in male infertility and sperm cryopreservation. The review also discusses the effect of cryopreservation on the activation of caspases in sperm, leading to apoptosis and decreased sperm quality. Finally, the article explores the use of caspase inhibitors as a strategy to improve sperm cryopreservation protocols and preserve sperm quality. Caspase 3 is the dominant effector caspase, while caspase 8 and 9 are involved in the extrinsic and intrinsic apoptotic pathways, respectively. Increased activity of these caspases has been associated with various sperm quality issues, such as teratozoospermia, asthenozoospermia, oligozoospermia and reduced cryostability. The review emphasizes the importance of understanding the role of caspases in sperm apoptosis and their potential as diagnostic markers and therapeutic targets for male infertility and sperm cryopreservation.
- 13 January 2025
- Published by Agricultural Research Communication Center in Indian Journal of Animal Research
- No. Of
Open AccessRole of Caspase 3, Caspase 8 and Caspase 9 in Male Infertility and Sperm Cryoinjury: A Review
Apoptosis is an integral part of sperm development, quality control and differentiation. Caspases are proteolytic enzymes that play a key role in apoptosis. The aim of this review article is to analyze the role of caspases 3, 8 and 9 in male infertility and sperm cryopreservation. The review also discusses the effect of cryopreservation on the activation of caspases in sperm, leading to apoptosis and decreased sperm quality. Finally, the article explores the use of caspase inhibitors as a strategy to improve sperm cryopreservation protocols and preserve sperm quality. Caspase 3 is the dominant effector caspase, while caspase 8 and 9 are involved in the extrinsic and intrinsic apoptotic pathways, respectively. Increased activity of these caspases has been associated with various sperm quality issues, such as teratozoospermia, asthenozoospermia, oligozoospermia and reduced cryostability. The review emphasizes the importance of understanding the role of caspases in sperm apoptosis and their potential as diagnostic markers and therapeutic targets for male infertility and sperm cryopreservation.
- Open Access
- 1 January 2025
- Published by Tech Science Press in BIOCELL
- Vol. 49 (11) , 2093-2123
Endothelial and Mitochondrial Dysfunction in COPD Pathophysiology: Focus on Homocysteine–L-Carnitine Interplay
Elevated homocysteine is a clinically relevant metabolic signal in chronic obstructive pulmonary disease (COPD). Higher circulating levels track with oxidative stress, endothelial dysfunction, mitochondrial impairment, and pulmonary vascular remodeling, rise with disease severity, and may contribute to the excess cardiovascular risk—although effect sizes and causality remain uncertain. This review centers on the homocysteine–carnitine relationship in COPD pathophysiology. Carnitine deficiency, prevalent in COPD, can worsen mitochondrial bioenergetics, promote accumulation of acyl intermediates, and reduce nitric oxide bioavailability via endothelial nitric oxide synthase uncoupling (eNOS). Conversely, restoring carnitine status in experimental and early clinical settings has been associated with lower homocysteine, improved nitric oxide signaling, and attenuation of vascular remodeling, suggesting a reciprocal link rather than a one-way pathway. We review existing evidence on various COPD phenotypes and severities, delineate mechanisms that connect homocysteine, carnitine metabolism, mitochondria, redox balance and eNOS uncoupling, and evaluate therapeutic strategies—ranging from lowering homocysteine with B-group vitamins to integrated approaches that also support mitochondrial function and redox homeostasis, including targeted carnitine supplementation. The role of L-carnitine as a potential therapeutic agent for lowering homocysteine and improving mitochondrial and vascular function warrants further investigation, as it may help slow the progression of COPD and its related comorbidities.
- 1 January 2025
- Published by Tech Science Press in BIOCELL
- Vol. 49 (11) , 2093-2123
Open AccessEndothelial and Mitochondrial Dysfunction in COPD Pathophysiology: Focus on Homocysteine–L-Carnitine Interplay
Elevated homocysteine is a clinically relevant metabolic signal in chronic obstructive pulmonary disease (COPD). Higher circulating levels track with oxidative stress, endothelial dysfunction, mitochondrial impairment, and pulmonary vascular remodeling, rise with disease severity, and may contribute to the excess cardiovascular risk—although effect sizes and causality remain uncertain. This review centers on the homocysteine–carnitine relationship in COPD pathophysiology. Carnitine deficiency, prevalent in COPD, can worsen mitochondrial bioenergetics, promote accumulation of acyl intermediates, and reduce nitric oxide bioavailability via endothelial nitric oxide synthase uncoupling (eNOS). Conversely, restoring carnitine status in experimental and early clinical settings has been associated with lower homocysteine, improved nitric oxide signaling, and attenuation of vascular remodeling, suggesting a reciprocal link rather than a one-way pathway. We review existing evidence on various COPD phenotypes and severities, delineate mechanisms that connect homocysteine, carnitine metabolism, mitochondria, redox balance and eNOS uncoupling, and evaluate therapeutic strategies—ranging from lowering homocysteine with B-group vitamins to integrated approaches that also support mitochondrial function and redox homeostasis, including targeted carnitine supplementation. The role of L-carnitine as a potential therapeutic agent for lowering homocysteine and improving mitochondrial and vascular function warrants further investigation, as it may help slow the progression of COPD and its related comorbidities.
- Open Access
- 9 July 2024
- Published by Agricultural Research Communication Center in Indian Journal of Animal Research
- No. Of
Importance of L-carnitine as Biochemical Marker for Semen Quality Preservation after Cryopreservation in Stallions
Background: The aim of this work is to study the significance of carnitine fractions and NO metabolites for the assessment of spermatozoa resistance to cryopreservation, for which purpose these parameters were investigated in seminal plasma of animals divided according to the indices of spermatozoa of stallions subjected to cryopreservation. Methods: There were 18 breeding stallions with an average age of 11.28±5.46 years, all 18 were of Arabian breed. Using cluster analysis of indicators of semen quality, animals were identified into two groups: with high and low sperm resistance to cryopreservation-thawing. We assessed standard quality parameters in fresh and cryopreserved sperm, as well as carnitine and its fractions and NO metabolites in stallions’ seminal plasma, steroid hormones level and carnitine fractions in blood serum. Data were analyzed using JASP. Differences at p less than 0.05 were considered statistically significant. Result: Seminal plasma obtained from animals from the cluster with low motility after cryopreservation-thawing was characterized by a lower concentration of nitric oxide metabolites in 1,79 time (p=0.0415) and free carnitine in 1,64 time (p=0.0349). Positive moderate strength correlation were established between the level of seminal plasma free carnitine and the percentage of live spermatozoa after sperm cryopreservation-thawing.
- 9 July 2024
- Published by Agricultural Research Communication Center in Indian Journal of Animal Research
- No. Of
Open AccessImportance of L-carnitine as Biochemical Marker for Semen Quality Preservation after Cryopreservation in Stallions
Background: The aim of this work is to study the significance of carnitine fractions and NO metabolites for the assessment of spermatozoa resistance to cryopreservation, for which purpose these parameters were investigated in seminal plasma of animals divided according to the indices of spermatozoa of stallions subjected to cryopreservation. Methods: There were 18 breeding stallions with an average age of 11.28±5.46 years, all 18 were of Arabian breed. Using cluster analysis of indicators of semen quality, animals were identified into two groups: with high and low sperm resistance to cryopreservation-thawing. We assessed standard quality parameters in fresh and cryopreserved sperm, as well as carnitine and its fractions and NO metabolites in stallions’ seminal plasma, steroid hormones level and carnitine fractions in blood serum. Data were analyzed using JASP. Differences at p less than 0.05 were considered statistically significant. Result: Seminal plasma obtained from animals from the cluster with low motility after cryopreservation-thawing was characterized by a lower concentration of nitric oxide metabolites in 1,79 time (p=0.0415) and free carnitine in 1,64 time (p=0.0349). Positive moderate strength correlation were established between the level of seminal plasma free carnitine and the percentage of live spermatozoa after sperm cryopreservation-thawing.
- Open Access
- 7 April 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (1) , 133-144
Role of Hypoxia-Inducible Factor 1α in Adaptation to Hypoxia in the Pathogenesis of Novel Coronavirus Disease 2019
INTRODUCTION: A novel coronavirus (severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2)) emerged in December 2019 and rapidly spread over the world having provoked a pandemic of respiratory disease. This highly pathogenic virus can attack the lung tissue and derange gas exchange leading to acute respiratory distress syndrome and systemic hypoxia. Hypoxic conditions trigger activation of adaptation mechanisms including hypoxia-inducible factor-1á (HIF-1á) which is involved in the regulation of the key processes, e. g, proliferation and metabolism of cells and angiogenesis. Besides, the level of HIF-1á expression is associated with the intensity of the immune response of an organism including that of the innate immunity mediating inflammatory reaction. Therefore, understanding the peculiarities of the mechanisms underlying the pathogenesis of this disease is of great importance for effective therapy of coronavirus disease 2019 (COVID-19). AIM: Analysis of the current data on HIF-1á and its effect on the pathogenesis and progression of COVID-19. The analysis of the relevant domestic and international literature sources was performed in the following sections: HIF-1á as a key factor of adaptation to hypoxia, targets for HIF-1á in the aspect of the pathogenesis of COVID-19, disorders in HIF-1á-mediated adaptation to hypoxia as an element of the pathogenesis of hyperactivation of the immune cells. CONCLUSION: HIF-1á prevents penetration of SARS-CoV-2 virus into a cell and primarily acts as the main regulator of the proinflammatory activity at the inflammation site surrounded by hypoxia. In the conditions of the deranged metabolic flexibility, a high level of HIF-1á evokes an excessive inflammatory response of the immune cells. A high HIF-1á level in cells of the inflammation focus is associated with enhanced production of the factors of angiogenesis mediating vascular permeability and capillary leakage process. This is accompanied by tissue damage and organ failure. At the same time, HIF-1á can mediate the anti-inflammatory effect through activation of adenosine receptor-dependent pathway, which is considered as a probable protection of cells and organs against damage by hyperactive immune cells.
- 7 April 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (1) , 133-144
Open AccessRole of Hypoxia-Inducible Factor 1α in Adaptation to Hypoxia in the Pathogenesis of Novel Coronavirus Disease 2019
INTRODUCTION: A novel coronavirus (severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2)) emerged in December 2019 and rapidly spread over the world having provoked a pandemic of respiratory disease. This highly pathogenic virus can attack the lung tissue and derange gas exchange leading to acute respiratory distress syndrome and systemic hypoxia. Hypoxic conditions trigger activation of adaptation mechanisms including hypoxia-inducible factor-1á (HIF-1á) which is involved in the regulation of the key processes, e. g, proliferation and metabolism of cells and angiogenesis. Besides, the level of HIF-1á expression is associated with the intensity of the immune response of an organism including that of the innate immunity mediating inflammatory reaction. Therefore, understanding the peculiarities of the mechanisms underlying the pathogenesis of this disease is of great importance for effective therapy of coronavirus disease 2019 (COVID-19). AIM: Analysis of the current data on HIF-1á and its effect on the pathogenesis and progression of COVID-19. The analysis of the relevant domestic and international literature sources was performed in the following sections: HIF-1á as a key factor of adaptation to hypoxia, targets for HIF-1á in the aspect of the pathogenesis of COVID-19, disorders in HIF-1á-mediated adaptation to hypoxia as an element of the pathogenesis of hyperactivation of the immune cells. CONCLUSION: HIF-1á prevents penetration of SARS-CoV-2 virus into a cell and primarily acts as the main regulator of the proinflammatory activity at the inflammation site surrounded by hypoxia. In the conditions of the deranged metabolic flexibility, a high level of HIF-1á evokes an excessive inflammatory response of the immune cells. A high HIF-1á level in cells of the inflammation focus is associated with enhanced production of the factors of angiogenesis mediating vascular permeability and capillary leakage process. This is accompanied by tissue damage and organ failure. At the same time, HIF-1á can mediate the anti-inflammatory effect through activation of adenosine receptor-dependent pathway, which is considered as a probable protection of cells and organs against damage by hyperactive immune cells.
- 26 March 2023
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 104 (2) , 165-175
The intensity of oxidative stress and systemic inflammation in patients with a combination of bronchial asthma and chronic obstructive pulmonary disease
Background. Chronic obstructive pulmonary disease and bronchial asthma, when combined in one patient, are characterized by a low level of control. Excess weight aggravates the course of obstructive diseases. The study of the features of this syntropy will improve the effectiveness of therapeutic measures. Aim. The study of the level of cytokines and carbonylated proteins in patients with a combination of bronchial asthma and chronic obstructive pulmonary disease with overweight and normal weight during an exacerbation. Material and methods. The study included 136 people: the first group a combination of bronchial asthma and chronic obstructive pulmonary disease (n=30), the second bronchial asthma (n=36), the third chronic obstructive pulmonary disease (n=29), the fourth volunteers without respiratory diseases (n=41). Each group was divided into two subgroups depending on the body mass index (less than 25 kg/m2 or 25 kg/m2 and more). The concentrations of interleukins-6 and -8, tumor necrosis factor in blood plasma were determined by enzyme immunoassay. The level of carbonylated plasma proteins was assessed spectrophotometrically. Statistical processing was performed in the Statistica 10.0 program using nonparametric criteria. The correlation of the studied parameters was assessed using the Spearman coefficient. Results. In patients with a combination of bronchial asthma and chronic obstructive pulmonary disease, statistically significant positive correlations between the levels of interleukins-6 and -8, tumor necrosis factor and carbonylated proteins were found 0.51, 0.59 and 0.55, respectively (p 0.05). Patients of the first group with overweight differed by 37.5% in higher levels of interleukin-6 compared with patients with body mass index 25 kg/m2. Conclusion. The intensity of systemic inflammation in patients with a combination of bronchial asthma and chronic obstructive pulmonary disease during exacerbation correlates with the intensity of oxidative damage.
- 26 March 2023
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 104 (2) , 165-175
The intensity of oxidative stress and systemic inflammation in patients with a combination of bronchial asthma and chronic obstructive pulmonary disease
Background. Chronic obstructive pulmonary disease and bronchial asthma, when combined in one patient, are characterized by a low level of control. Excess weight aggravates the course of obstructive diseases. The study of the features of this syntropy will improve the effectiveness of therapeutic measures. Aim. The study of the level of cytokines and carbonylated proteins in patients with a combination of bronchial asthma and chronic obstructive pulmonary disease with overweight and normal weight during an exacerbation. Material and methods. The study included 136 people: the first group a combination of bronchial asthma and chronic obstructive pulmonary disease (n=30), the second bronchial asthma (n=36), the third chronic obstructive pulmonary disease (n=29), the fourth volunteers without respiratory diseases (n=41). Each group was divided into two subgroups depending on the body mass index (less than 25 kg/m2 or 25 kg/m2 and more). The concentrations of interleukins-6 and -8, tumor necrosis factor in blood plasma were determined by enzyme immunoassay. The level of carbonylated plasma proteins was assessed spectrophotometrically. Statistical processing was performed in the Statistica 10.0 program using nonparametric criteria. The correlation of the studied parameters was assessed using the Spearman coefficient. Results. In patients with a combination of bronchial asthma and chronic obstructive pulmonary disease, statistically significant positive correlations between the levels of interleukins-6 and -8, tumor necrosis factor and carbonylated proteins were found 0.51, 0.59 and 0.55, respectively (p 0.05). Patients of the first group with overweight differed by 37.5% in higher levels of interleukin-6 compared with patients with body mass index 25 kg/m2. Conclusion. The intensity of systemic inflammation in patients with a combination of bronchial asthma and chronic obstructive pulmonary disease during exacerbation correlates with the intensity of oxidative damage.
- Open Access
- 28 December 2022
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 30 (4) , 457-470
Protective Effects of L-Arginine on Mitochondria of Rat Epididymis in Hyperhomocysteinemia Induced by Prolonged Methionine Load
INTRODUCTION: The study of markers of oxidative stress, metabolites of nitric oxide (II) (NOx) and the balance of carnitine fractions in mitochondria of rat epididymis, permits to evaluate the protective role of L-arginine in experimental hyperhomocysteinemia. AIM: To study the influence of L-arginine on the parameters of energy metabolism, level of NO metabolites, oxidative modification of proteins and balance of carnitine fractions in mitochondria of the head and tail of rat epididymis in hyperhomocysteinemia. MATERIALS AND METHODS: In animals of group 1 (n = 8), severe hyperhomocysteinemia (HHcy) was modeled by administration of methionine suspension at a dose of 1.5 g/kg twice daily for 21 days with addition of 1% methionine in drinking water; group 2 rats (n = 8) received suspension base without methionine; animals of group 3 (n = 8) were daily administered L-arginine solution at a dose of 500 mg/kg intragastrically against the background methionine load from day 11 to day 21; group 4 animals (n = 8) were administered L-arginine solution of at a dose of 500 mg/kg for 10 days; group 5 (n = 8) served as a control for group 4 and received drinking water intragastrically. Concentrations of total homocysteine and NOx were determined in serum. In the mitochondrial fraction of the homogenate of epididymis tissues, the level of oxidatively modified proteins (OMP), the concentration of NOx, lactate and carnitine fractions, the activity of lactate dehydrogenase (LDH), superoxide dismutase (SOD), H+-ATPase, succinate dehydrogenase (SDH) were evaluated. RESULTS: HHcy was accompanied by reduction of the level of NOx in blood serum and mitochondria of epididymis head tissues. In mitochondria of tissues of head and tail of epididymis, a marked reduction of all fractions of carnitine, activity of LDH, H+-ATPase, SDH, increase in the activity of SOD and in the level of OMP were observed. With modeled HHcy, L-arginine reduced the extent of hyperhomocysteinemia, prevented reduction of NOx level in the blood serum and epididymis head and reduced the content of OMP of the epididymis mitochondria. CONCLUSION: L-arginine introduced in combination with methionine, reduces the extent of severity of hyperhomocysteinemia. The positive effect of L-arginine on increase in the concentration of NOx metabolites in blood serum and mitochondria of epididymis in conditions of methionine load was also confirmed. L-arginine exhibits antioxidant properties, reducing the severity of oxidative stress induced by hyperhomocysteinemia. Differences in the adaptive response to oxidative stress of the mitochondria of the head and tail of epididymis were demonstrated.
- 28 December 2022
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 30 (4) , 457-470
Open AccessProtective Effects of L-Arginine on Mitochondria of Rat Epididymis in Hyperhomocysteinemia Induced by Prolonged Methionine Load
INTRODUCTION: The study of markers of oxidative stress, metabolites of nitric oxide (II) (NOx) and the balance of carnitine fractions in mitochondria of rat epididymis, permits to evaluate the protective role of L-arginine in experimental hyperhomocysteinemia. AIM: To study the influence of L-arginine on the parameters of energy metabolism, level of NO metabolites, oxidative modification of proteins and balance of carnitine fractions in mitochondria of the head and tail of rat epididymis in hyperhomocysteinemia. MATERIALS AND METHODS: In animals of group 1 (n = 8), severe hyperhomocysteinemia (HHcy) was modeled by administration of methionine suspension at a dose of 1.5 g/kg twice daily for 21 days with addition of 1% methionine in drinking water; group 2 rats (n = 8) received suspension base without methionine; animals of group 3 (n = 8) were daily administered L-arginine solution at a dose of 500 mg/kg intragastrically against the background methionine load from day 11 to day 21; group 4 animals (n = 8) were administered L-arginine solution of at a dose of 500 mg/kg for 10 days; group 5 (n = 8) served as a control for group 4 and received drinking water intragastrically. Concentrations of total homocysteine and NOx were determined in serum. In the mitochondrial fraction of the homogenate of epididymis tissues, the level of oxidatively modified proteins (OMP), the concentration of NOx, lactate and carnitine fractions, the activity of lactate dehydrogenase (LDH), superoxide dismutase (SOD), H+-ATPase, succinate dehydrogenase (SDH) were evaluated. RESULTS: HHcy was accompanied by reduction of the level of NOx in blood serum and mitochondria of epididymis head tissues. In mitochondria of tissues of head and tail of epididymis, a marked reduction of all fractions of carnitine, activity of LDH, H+-ATPase, SDH, increase in the activity of SOD and in the level of OMP were observed. With modeled HHcy, L-arginine reduced the extent of hyperhomocysteinemia, prevented reduction of NOx level in the blood serum and epididymis head and reduced the content of OMP of the epididymis mitochondria. CONCLUSION: L-arginine introduced in combination with methionine, reduces the extent of severity of hyperhomocysteinemia. The positive effect of L-arginine on increase in the concentration of NOx metabolites in blood serum and mitochondria of epididymis in conditions of methionine load was also confirmed. L-arginine exhibits antioxidant properties, reducing the severity of oxidative stress induced by hyperhomocysteinemia. Differences in the adaptive response to oxidative stress of the mitochondria of the head and tail of epididymis were demonstrated.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Evaluation of mitochondrial dysfunction of mononuclear leukocytes of smokers and ex-smokers in COPD exacerbation
Introduction: The mitochondrial membrane potential (Δψ) and level of carbonylated proteins in mononuclear leukocytes of peripheral blood (ML) is of interest as a possible marker of systemic mitochondrial dysfunction in COPD. Aim: Evaluation of the indicators of secondary mitochondrial dysfunction of ML in smokers and ex-smokers with exacerbation of COPD. Methods: The study included 25 people. The control group consisted of 8 healthy volunteers. 17 patients with non-infectious exacerbation of COPD were divided into groups of comparable age: smokers (n=9) and ex-smokers (n=8). Blood was taken on the second day of hospitalization using the BD Vacutainer CPT. Δψ of ML was assessed using the JC-1 Assay Kit on a FC 500 flow cytometer using Cyflogic. The level of carbonylated proteins (CP) of ML was determined spectrophotometrically in terms of 106cells/ml [Fomina N.V., et al. Angiol Sosud Khir.2015;21(1):29-34]. Results: Δψ in ML of the control group was 0.318± 0.031 and was higher relative to the group of smokers (0.244±0.046;p=0.01). When comparing the Δψ of ML in the control group and ex-smokers (0.297±0.047), differences were not found. Smokers ML characterized by the higher content of CP (234[221;452]) relative to the ex-smokers (169[101;237];p=0.04). The CP level of ML in the control group (21[16;65]) was lower both in comparison with the group of smokers (p= 0.0006) and ex-smokers (p=0.005). Conclusions: Smokers are characterized by a pronounced decrease in Δψ of mitochondria of mononuclear leukocytes in exacerbation of COPD compared with ex-smokers. A high level of carbonylated proteins in smokers indicates a greater severity of oxidative stress in this group of patients.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Evaluation of mitochondrial dysfunction of mononuclear leukocytes of smokers and ex-smokers in COPD exacerbation
Introduction: The mitochondrial membrane potential (Δψ) and level of carbonylated proteins in mononuclear leukocytes of peripheral blood (ML) is of interest as a possible marker of systemic mitochondrial dysfunction in COPD. Aim: Evaluation of the indicators of secondary mitochondrial dysfunction of ML in smokers and ex-smokers with exacerbation of COPD. Methods: The study included 25 people. The control group consisted of 8 healthy volunteers. 17 patients with non-infectious exacerbation of COPD were divided into groups of comparable age: smokers (n=9) and ex-smokers (n=8). Blood was taken on the second day of hospitalization using the BD Vacutainer CPT. Δψ of ML was assessed using the JC-1 Assay Kit on a FC 500 flow cytometer using Cyflogic. The level of carbonylated proteins (CP) of ML was determined spectrophotometrically in terms of 106cells/ml [Fomina N.V., et al. Angiol Sosud Khir.2015;21(1):29-34]. Results: Δψ in ML of the control group was 0.318± 0.031 and was higher relative to the group of smokers (0.244±0.046;p=0.01). When comparing the Δψ of ML in the control group and ex-smokers (0.297±0.047), differences were not found. Smokers ML characterized by the higher content of CP (234[221;452]) relative to the ex-smokers (169[101;237];p=0.04). The CP level of ML in the control group (21[16;65]) was lower both in comparison with the group of smokers (p= 0.0006) and ex-smokers (p=0.005). Conclusions: Smokers are characterized by a pronounced decrease in Δψ of mitochondria of mononuclear leukocytes in exacerbation of COPD compared with ex-smokers. A high level of carbonylated proteins in smokers indicates a greater severity of oxidative stress in this group of patients.